Examination of angiopoietin-like protein 4, neuropeptide Y, omentin-1 levels of obese and non-obese patients with polycystic ovary syndrome

Gynecological Endocrinology

Volumn 31, Issue 11, 2015, Pages 903-906

  Güneş, Meryem ^a   Bukan, Neslihan ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Angptl 4; NPY; obesity; omentin 1; polycystic ovary syndrome

Indexed keywords

ANDROSTENEDIONE; ANGIOPOIETIN LIKE PROTEIN 4; ESTRADIOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; NEUROPEPTIDE Y; OMENTIN 1; PRASTERONE SULFATE; PROTEIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ANGIOPOIETIN; ANGPTL4 PROTEIN, HUMAN; CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN;

ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FERRIMAN GALWEY SCORE; HUMAN; INSULIN RESISTANCE; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; UROGENITAL TRACT DISEASE ASSESSMENT; WAIST CIRCUMFERENCE; ADULT; BLOOD; CASE CONTROL STUDY; COMPLICATION; METABOLISM;

ADULT; ANDROSTENEDIONE; ANGIOPOIETINS; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CYTOKINES; DEHYDROEPIANDROSTERONE SULFATE; ESTRADIOL; FEMALE; GPI-LINKED PROTEINS; HUMANS; INSULIN RESISTANCE; LECTINS; LUTEINIZING HORMONE; NEUROPEPTIDE Y; OBESITY; POLYCYSTIC OVARY SYNDROME; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; TRIGLYCERIDES;

EID: 84949539025     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2015.1068285     Document Type: Article

References (16)

1. Wiltgen D, Benedetto IG, Mastella LS, Spritzer PM. Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome. Hum Reprod 2009; 24: 1726-31
2. Baranowska B, Kozbicka G, Jeske W, Abel-Fattah H. The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa. The effect of naloxone on LH, FSH, prolactin and 0-endorphin secretion. J Clin Endocrinol Metab 1984; 59: 412-16
3. Homburg R. Androgen circle of polycystic ovary syndrome. Hum Reprod 2009; 24: 1548-55
4. Deshmukh S. Polycystic ovarian syndrome. In: Allahbadia GN., ed. Infertility management made easy. Tunbridge Wells, England: Anshan Ltd; 2007: 172-97
5. Gehlert DR. Role of hypothalamic neuropeptide Y in feeding, and obesity. Neuropeptides 1999; 33: 329-38
6. Wurm S, Neumeier M, Weigert J, et al. Plasma levels of leptin, omentin, collagenous repeat-containing sequence of 26-kDa protein (CORS-26) and adiponectin before and after oral glucose uptake in slim adults. Cardiovasc Diabetol 2007; 6: 7. doi: 10.1186/1475-2840-6-7
7. Kim HK, Youn BS, Shin MS, et al. Hypothalamic Angptl4/Fiaf is a novel regulator of food intake and body weight. Diabetes 2010; 59: 2772-80
8. Azziz R, Carmina E, Dewailly D, et al. Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome. An Androgen Excess Society Guideline 2006; 91: 4237
9. WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rp Ser 2000; 894: 1-253
10. Beck B, Burlet A, Nicolas J-P, Burlet C. hypothalamic neuropeptide Y (NPY) in obese Zucker rats: implications in feeding and sexual behavior. Physiol Behav 1990; 47: 449-53
11. Kalra SP, Dube MG, Sahu A, et al. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc Natl Acad Sci USA 1991; 88: 10931-5
12. Baranowska B, Radzikowska M, Wasilewska-Dziubihska E, et al. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome. Gynecol Endocrinol 1999; 13: 344-51
13. Pan H-Y, Guo L, Li Q. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract 2010; 88: 29-33
14. Choi JH, Rhee EJ, Kim KH, et al. Plasma omentin-1 levels are reduced in non-obese women with normal glucose tolerance and polycystic ovary syndrome. Eur J Endocrinol 2011; 165: 789-96
15. Tan BK, Adya R, Farhatullah S, et al. Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes [serial online] 2008; 57: 801-8
16. Oike Y, Akao M, Kubota Y, et al. Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy. Trends Mol Med 2005; 11: 473-9